The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 09, 2019

Filed:

Feb. 17, 2017
Applicant:

Immundiagnostik Ag, Bensheim, DE;

Inventors:

Franz Paul Armbruster, Bensheim, DE;

Berthold Hocher, Berlin, DE;

Assignee:

Immundiagnostik AG, Bensheim, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61M 1/34 (2006.01); A61K 35/14 (2015.01); A61K 35/16 (2015.01); G01N 33/68 (2006.01); C07K 16/18 (2006.01); C07K 16/24 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 35/14 (2013.01); A61K 35/16 (2013.01); A61M 1/3486 (2014.02); A61M 1/3496 (2013.01); C07K 16/24 (2013.01); G01N 33/6893 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); G01N 2333/47 (2013.01); G01N 2800/347 (2013.01);
Abstract

The present invention provides a novel therapy concept based on a removal of circulation BSP (bone sialoprotein) from the plasma of patients with chronic kidney disease (CKD), preferably by plasmapheresis or an administration of antibodies against BSP in plasma. The present invention further provides a BSP absorber material for plasmapheresis and a pharmaceutical composition namely in form of anti-BSP antibodies for direct administration which are biocompatible in humans. The beneficial effects of this therapy have been proven by the observed correspondence between levels of circulating free BSP levels and mortality of CKD patients.


Find Patent Forward Citations

Loading…